These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22999273)

  • 1. iPSC technology to study human aging and aging-related disorders.
    Liu GH; Ding Z; Izpisua Belmonte JC
    Curr Opin Cell Biol; 2012 Dec; 24(6):765-74. PubMed ID: 22999273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.
    Payne NL; Sylvain A; O'Brien C; Herszfeld D; Sun G; Bernard CC
    N Biotechnol; 2015 Jan; 32(1):212-28. PubMed ID: 24815224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases].
    Ito D; Yagi T; Suzuki N
    Brain Nerve; 2013 Mar; 65(3):283-8. PubMed ID: 23475520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hutchinson-Gilford progeria syndrome as a model for vascular aging.
    Brassard JA; Fekete N; Garnier A; Hoesli CA
    Biogerontology; 2016 Feb; 17(1):129-45. PubMed ID: 26330290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro pathological modelling using patient-specific induced pluripotent stem cells: the case of progeria.
    Nissan X; Blondel S; Peschanski M
    Biochem Soc Trans; 2011 Dec; 39(6):1775-9. PubMed ID: 22103524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cell models of lysosomal storage disorders.
    Borger DK; McMahon B; Roshan Lal T; Serra-Vinardell J; Aflaki E; Sidransky E
    Dis Model Mech; 2017 Jun; 10(6):691-704. PubMed ID: 28592657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honing the Double-Edged Sword: Improving Human iPSC-Microglia Models.
    Hedegaard A; Stodolak S; James WS; Cowley SA
    Front Immunol; 2020; 11():614972. PubMed ID: 33363548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generating Late-Onset Human iPSC-Based Disease Models by Inducing Neuronal Age-Related Phenotypes through Telomerase Manipulation.
    Vera E; Bosco N; Studer L
    Cell Rep; 2016 Oct; 17(4):1184-1192. PubMed ID: 27760320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential of iPSCs for the Treatment of Premature Aging Disorders.
    Compagnucci C; Bertini E
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29112121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells for modeling of pediatric neurological disorders.
    Jang J; Quan Z; Yum YJ; Song HS; Paek S; Kang HC
    Biotechnol J; 2014 Jul; 9(7):871-81. PubMed ID: 24838856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cells: from derivation to application in biochemical and biomedical research.
    Novosadova EV; Grivennikov IA
    Biochemistry (Mosc); 2014 Dec; 79(13):1425-41. PubMed ID: 25749158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in reprogramming-based study of neurologic disorders.
    Nityanandam A; Baldwin KK
    Stem Cells Dev; 2015 Jun; 24(11):1265-83. PubMed ID: 25749371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Back and forth in time: Directing age in iPSC-derived lineages.
    Cornacchia D; Studer L
    Brain Res; 2017 Feb; 1656():14-26. PubMed ID: 26592774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iPSCs: On the Road to Reprogramming Aging.
    Soria-Valles C; López-Otín C
    Trends Mol Med; 2016 Aug; 22(8):713-724. PubMed ID: 27286740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise Review: Induced Pluripotent Stem Cell Research in the Era of Precision Medicine.
    Hamazaki T; El Rouby N; Fredette NC; Santostefano KE; Terada N
    Stem Cells; 2017 Mar; 35(3):545-550. PubMed ID: 28100040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects.
    Zhang J; Lian Q; Zhu G; Zhou F; Sui L; Tan C; Mutalif RA; Navasankari R; Zhang Y; Tse HF; Stewart CL; Colman A
    Cell Stem Cell; 2011 Jan; 8(1):31-45. PubMed ID: 21185252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of disease-specific autopsy-confirmed iPSCs lines from postmortem isolated Peripheral Blood Mononuclear Cells.
    Belle K; Shabazz FS; Nuytemans K; Davis DA; Ali A; Young JL; Scott WK; Mash DC; Vance JM; Dykxhoorn DM
    Neurosci Lett; 2017 Jan; 637():201-206. PubMed ID: 27826014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders.
    Qiang L; Fujita R; Abeliovich A
    Neuron; 2013 Jun; 78(6):957-69. PubMed ID: 23791192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.